[1]
M. N.V.N., “SCALE UP AND POSTAPPROVAL CHANGES (SUPAC) GUIDANCE FOR INDUSTRY: A REGULATORY NOTE”, Int J Drug Reg Affairs, vol. 5, no. 1, pp. 13-19, Feb. 2018.